Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 1
1917 1
1918 1
1920 1
1923 1
1925 2
1927 1
1928 2
1929 2
1930 4
1932 2
1935 2
1936 1
1937 1
1940 1
1945 1
1946 7
1947 7
1948 10
1949 11
1950 27
1951 27
1952 24
1953 25
1954 20
1955 28
1956 22
1957 14
1958 25
1959 13
1960 8
1961 8
1962 5
1963 6
1964 7
1965 28
1966 46
1967 55
1968 52
1969 56
1970 64
1971 73
1972 57
1973 73
1974 55
1975 55
1976 59
1977 57
1978 80
1979 74
1980 71
1981 75
1982 58
1983 64
1984 87
1985 90
1986 82
1987 90
1988 86
1989 71
1990 101
1991 72
1992 77
1993 103
1994 102
1995 128
1996 76
1997 92
1998 91
1999 82
2000 111
2001 113
2002 86
2003 114
2004 107
2005 99
2006 109
2007 108
2008 133
2009 147
2010 159
2011 156
2012 184
2013 166
2014 154
2015 153
2016 140
2017 161
2018 154
2019 155
2020 170
2021 154
2022 138
2023 158
2024 108

Text availability

Article attribute

Article type

Publication date

Search Results

5,945 results

Results by year

Filters applied: . Clear all
Page 1
Hypothalamic syndrome.
Müller HL, Tauber M, Lawson EA, Özyurt J, Bison B, Martinez-Barbera JP, Puget S, Merchant TE, van Santen HM. Müller HL, et al. Nat Rev Dis Primers. 2022 Apr 21;8(1):24. doi: 10.1038/s41572-022-00351-z. Nat Rev Dis Primers. 2022. PMID: 35449162 Review.
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival.
Rinke A, Wittenberg M, Schade-Brittinger C, Aminossadati B, Ronicke E, Gress TM, Müller HH, Arnold R; PROMID Study Group. Rinke A, et al. Neuroendocrinology. 2017;104(1):26-32. doi: 10.1159/000443612. Epub 2016 Jan 6. Neuroendocrinology. 2017. PMID: 26731483 Free article. Clinical Trial.
Editorial: Hypothalamic obesity: Today and future.
van Santen HM, Spinedi E, Muller HL. van Santen HM, et al. Front Endocrinol (Lausanne). 2022 Oct 3;13:1025440. doi: 10.3389/fendo.2022.1025440. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36263319 Free PMC article. No abstract available.
Childhood-onset Craniopharyngioma-a Life-long Family Burden?
Beckhaus J, Friedrich C, Müller HL. Beckhaus J, et al. J Clin Endocrinol Metab. 2024 Apr 19;109(5):e1404-e1405. doi: 10.1210/clinem/dgad613. J Clin Endocrinol Metab. 2024. PMID: 37847153 No abstract available.
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, Harder J, Arnold C, Gress T, Arnold R; PROMID Study Group. Rinke A, et al. J Clin Oncol. 2009 Oct 1;27(28):4656-63. doi: 10.1200/JCO.2009.22.8510. Epub 2009 Aug 24. J Clin Oncol. 2009. PMID: 19704057 Clinical Trial.
Microbiology of aggressive periodontitis.
Könönen E, Müller HP. Könönen E, et al. Periodontol 2000. 2014 Jun;65(1):46-78. doi: 10.1111/prd.12016. Periodontol 2000. 2014. PMID: 24738586 Review.
5,945 results